14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $57.55 $79.59 Thursday, 2nd May 2024 EXAS stock ended at $60.54. This is 0.88% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.47% from a day low at $59.13 to a day high of $61.18.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Jan 21, 2021 $150.90 $151.19 $147.01 $148.07 1 255 032
Jan 20, 2021 $151.48 $152.87 $148.23 $150.37 1 635 141
Jan 19, 2021 $147.98 $151.53 $146.56 $148.83 1 859 475
Jan 15, 2021 $148.52 $149.60 $142.33 $145.97 1 526 570
Jan 14, 2021 $146.12 $149.87 $144.52 $147.29 1 338 427
Jan 13, 2021 $148.15 $148.46 $142.43 $145.37 1 669 333
Jan 12, 2021 $146.44 $152.68 $145.50 $148.42 2 220 098
Jan 11, 2021 $132.93 $152.48 $132.49 $144.00 5 764 371
Jan 08, 2021 $129.66 $133.72 $129.04 $131.10 1 538 888
Jan 07, 2021 $124.60 $131.19 $124.01 $130.70 1 898 439
Jan 06, 2021 $125.74 $127.05 $122.56 $124.28 1 766 676
Jan 05, 2021 $129.90 $130.43 $125.14 $126.88 1 538 765
Jan 04, 2021 $128.20 $131.78 $126.21 $128.77 1 208 151
Dec 31, 2020 $135.78 $136.27 $132.26 $132.49 742 002
Dec 30, 2020 $133.67 $135.78 $132.85 $135.40 881 450
Dec 29, 2020 $136.14 $137.25 $127.64 $132.10 1 323 866
Dec 28, 2020 $140.75 $141.85 $134.18 $135.77 1 006 202
Dec 24, 2020 $141.69 $142.34 $138.31 $139.56 358 852
Dec 23, 2020 $143.02 $144.00 $140.04 $141.00 1 248 566
Dec 22, 2020 $142.70 $143.85 $139.25 $142.12 2 025 944
Dec 21, 2020 $133.33 $142.98 $132.40 $141.04 1 937 912
Dec 18, 2020 $137.21 $138.12 $134.50 $137.05 2 355 888
Dec 17, 2020 $128.37 $136.77 $126.31 $136.04 2 638 185
Dec 16, 2020 $129.46 $129.89 $126.86 $127.33 914 214
Dec 15, 2020 $130.57 $131.76 $127.83 $129.39 1 227 589
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT